$273 Million is the total value of PURA VIDA INVESTMENTS, LLC's 70 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 275.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRput | $19,559,000 | – | 87,500 | +100.0% | 7.17% | – |
XLV | New | SELECT SECTOR SPDR TRput | $11,892,000 | – | 172,500 | +100.0% | 4.36% | – |
UNH | New | UNITEDHEALTH GROUP INC | $10,003,000 | – | 62,500 | +100.0% | 3.67% | – |
ATHN | Buy | ATHENAHEALTH INC | $9,991,000 | +44.0% | 95,000 | +72.7% | 3.66% | +73.8% |
ABBV | New | ABBVIE INC | $9,416,000 | – | 150,375 | +100.0% | 3.45% | – |
EVHC | New | ENVISION HEALTHCARE CORP | $8,965,000 | – | 141,644 | +100.0% | 3.29% | – |
HOLX | New | HOLOGIC INC | $8,603,000 | – | 214,425 | +100.0% | 3.15% | – |
BSX | Buy | BOSTON SCIENTIFIC CORP | $8,219,000 | +72.7% | 380,000 | +90.0% | 3.01% | +108.4% |
BCR | New | BARD C R INC | $8,200,000 | – | 36,500 | +100.0% | 3.01% | – |
IWM | New | ISHARES TRput | $8,091,000 | – | 60,000 | +100.0% | 2.97% | – |
IEV | New | ISHARES TReurope etf | $7,219,000 | – | 186,000 | +100.0% | 2.65% | – |
NUVA | New | NUVASIVE INC | $7,073,000 | – | 105,000 | +100.0% | 2.59% | – |
HUM | New | HUMANA INC | $6,835,000 | – | 33,500 | +100.0% | 2.51% | – |
PEN | Buy | PENUMBRA INC | $6,061,000 | +59.5% | 95,000 | +90.0% | 2.22% | +92.5% |
SYK | New | STRYKER CORPput | $5,991,000 | – | 50,000 | +100.0% | 2.20% | – |
BIO | New | BIO RAD LABS INCcl a | $5,560,000 | – | 30,500 | +100.0% | 2.04% | – |
GMED | New | GLOBUS MED INCcl a | $4,962,000 | – | 200,000 | +100.0% | 1.82% | – |
CYNO | Buy | CYNOSURE INCcl a | $4,560,000 | +49.2% | 100,000 | +66.7% | 1.67% | +80.2% |
ILMN | New | ILLUMINA INC | $4,481,000 | – | 35,000 | +100.0% | 1.64% | – |
INGN | New | INOGEN INCput | $4,366,000 | – | 65,000 | +100.0% | 1.60% | – |
BSX | New | BOSTON SCIENTIFIC CORPcall | $4,326,000 | – | 200,000 | +100.0% | 1.59% | – |
TMO | New | THERMO FISHER SCIENTIFIC INCput | $4,233,000 | – | 30,000 | +100.0% | 1.55% | – |
GKOS | New | GLAUKOS CORP | $3,770,000 | – | 109,903 | +100.0% | 1.38% | – |
GWPH | Buy | GW PHARMACEUTICALS PLCads | $3,604,000 | -2.5% | 32,250 | +15.8% | 1.32% | +17.6% |
NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $3,597,000 | +85.6% | 161,311 | +66.3% | 1.32% | +123.9% |
QSII | New | QUALITY SYS INC | $3,506,000 | – | 266,617 | +100.0% | 1.28% | – |
CFMS | New | CONFORMIS INC | $3,396,000 | – | 419,235 | +100.0% | 1.24% | – |
ICUI | New | ICU MED INC | $3,315,000 | – | 22,500 | +100.0% | 1.22% | – |
ELGX | New | ENDOLOGIX INC | $2,860,000 | – | 500,000 | +100.0% | 1.05% | – |
LPNT | New | LIFEPOINT HEALTH INCput | $2,840,000 | – | 50,000 | +100.0% | 1.04% | – |
XRAY | New | DENTSPLY SIRONA INC | $2,742,000 | – | 47,500 | +100.0% | 1.00% | – |
EWA | New | ISHAREScall | $2,024,000 | – | 100,000 | +100.0% | 0.74% | – |
QSII | New | QUALITY SYS INCcall | $1,911,000 | – | 145,300 | +100.0% | 0.70% | – |
Buy | NEURODERM LTD | $1,780,000 | +139.6% | 80,183 | +99.5% | 0.65% | +188.9% | |
ANIP | New | ANI PHARMACEUTICALS INC | $1,591,000 | – | 26,250 | +100.0% | 0.58% | – |
SUPN | New | SUPERNUS PHARMACEUTICALS INC | $1,389,000 | – | 55,000 | +100.0% | 0.51% | – |
ARRY | Buy | ARRAY BIOPHARMA INC | $1,383,000 | +581.3% | 157,360 | +424.5% | 0.51% | +717.7% |
IMMU | Buy | IMMUNOMEDICS INC | $1,235,000 | +18.9% | 336,500 | +5.3% | 0.45% | +43.4% |
AGRX | Buy | AGILE THERAPEUTICS INC | $938,000 | +439.1% | 164,501 | +560.6% | 0.34% | +549.1% |
ALDX | Buy | ALDEYRA THERAPEUTICS INC | $669,000 | -25.0% | 125,000 | +9.6% | 0.24% | -9.6% |
XENT | New | INTERSECT ENT INCcall | $645,000 | – | 3,000 | +100.0% | 0.24% | – |
OCRX | Buy | OCERA THERAPEUTICS INC | $544,000 | -17.2% | 258,893 | +4.0% | 0.20% | -0.5% |
BVX | New | BOVIE MEDICAL CORP | $442,000 | – | 123,000 | +100.0% | 0.16% | – |
AXGN | New | AXOGEN INC | $222,000 | – | 24,700 | +100.0% | 0.08% | – |
ELGX | New | ENDOLOGIX INCput | $26,000 | – | 4,600 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.